Advertisement

Picture Berlin Partner Top News How Covid Effects the Brain 650x100px
Person › Details

Jan van de Winkel (Genmab A/S (CSE: GEN, Nasdaq: GMAB))

van de Winkel, Jan (Genmab 201106 CEO before CSO + Co-Founder before Medarex Europe)

 

Organisation Organisation Genmab A/S (CSE: GEN, Nasdaq: GMAB)
  Group Genmab (Group)
Products Product DuoBody technology platform (bispecific antibodies)
  Product 2 Arzerra®
     

   
Record changed: 2023-04-17

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px


More documents for Jan van de Winkel


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top